These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13985777)

  • 21. [THE MEDICAMENTOUS TREATMENT OF COMMON ARTERIAL HYPERTENSION].
    FRITEL D
    Rev Prat; 1963 Dec; 13():3999-4007. PubMed ID: 14100439
    [No Abstract]   [Full Text] [Related]  

  • 22. PRESSOR RESPONSES TO NOXIOUS STIMULI IN HYPERTENSIVE PATIENTS: EFFECTS OF GUANETHIDINE SULFATE AND ALPHA METHYLDOPA.
    SHAPIRO AP; KRIFCHER E
    Circulation; 1964 Nov; 30():671-8. PubMed ID: 14230935
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies of the modification of central effects of 3,4-dioxyphenyl-alanine (DOPA) by alpha-methyl-dioxyphenylalanine (alpha-methyl-DOPA)].
    Matthies H; Fähse C; Lietz W
    Acta Biol Med Ger; 1967; 19(4):529-34. PubMed ID: 5596674
    [No Abstract]   [Full Text] [Related]  

  • 24. The sedative and lethal actions of reserpine in mice, as modified by 5-hydroxytryptophan, 3,4-dihydroxyphenylalanine, methylphenidate, and nikethamide in cold and warm environments.
    AIRAKSINEN MM; MATTILA M
    Acta Pharmacol Toxicol (Copenh); 1962; 19():199-204. PubMed ID: 14011421
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance.
    Mohammed S; Gaffney TE; Yard AC; Gomez H
    J Pharmacol Exp Ther; 1968 Apr; 160(2):300-7. PubMed ID: 5651373
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in vascular reactivity of the cat evoked by reserpine, guanethidine and alpha-methyldopa].
    Miele E
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):390-406. PubMed ID: 4288971
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopa.
    KIRKENDALL WM; WILSON WR
    Am J Cardiol; 1962 Jan; 9():107-15. PubMed ID: 14456308
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC).
    Miller RD; Way WL; Eger EI
    Anesthesiology; 1968; 29(6):1153-8. PubMed ID: 5726752
    [No Abstract]   [Full Text] [Related]  

  • 29. TOXICITY OF HYPOTENSIVE DRUGS.
    WILSON GM
    Practitioner; 1965 Jan; 194():51-5. PubMed ID: 14259691
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE PRESENT STATUS OF ANTIHYPERTENSIVE DRUG THERAPY].
    ARNOLD OH
    Munch Med Wochenschr; 1964 Oct; 106():1969-73. PubMed ID: 14333800
    [No Abstract]   [Full Text] [Related]  

  • 31. Relative effects of L-DOPA and its methyl ester given orally or intraperitoneally to reserpine-treated mice.
    Utley JD; Carlsson A
    Acta Pharmacol Toxicol (Copenh); 1965; 23(2):189-93. PubMed ID: 5899279
    [No Abstract]   [Full Text] [Related]  

  • 32. [THERAPY OF ESSENTIAL HYPERTENSION].
    ARNOLD OH
    Dtsch Med Wochenschr; 1965 Jan; 90():36-8. PubMed ID: 14225053
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective potentiation of sympathomimetic amines by reserpine. syrosingopine and 2,6-xylylcholine ether bromide (TM-10) in the dog.
    ROSS CA; WENGER HC; LUDDEN CT; STONE CA
    Arch Int Pharmacodyn Ther; 1963 Mar; 142():141-51. PubMed ID: 13975072
    [No Abstract]   [Full Text] [Related]  

  • 34. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    Br J Pharmacol Chemother; 1964 Feb; 22(1):72-86. PubMed ID: 14126060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of reserpine, guanethidine and methyldopa on general and regional hemodynamics].
    Iuzhakov SD; Kotliarov EV
    Farmakol Toksikol; 1973; 26(4):429-32. PubMed ID: 4789888
    [No Abstract]   [Full Text] [Related]  

  • 37. [DRUGS AND ELECTROSHOCK].
    HEYMANS C; DESCHAEPDRYVER AF; DELAUNOIS AL; PIETTE Y
    Riforma Med; 1964 Jan; 78():1-6. PubMed ID: 14127208
    [No Abstract]   [Full Text] [Related]  

  • 38. [SEVERE NEUROLOGICAL SIDE-EFFECTS IN HYPOTENSION THERAPY].
    BOETTIGER LE; MALMBORG RO; MICHAELI EW
    Nord Med; 1964 Apr; 71():523-5. PubMed ID: 14131560
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of reserpine, isobarin and dopegit on the resistance of cerebral vessels].
    Beketov AI; Svistov VV; Tkachenko BI; Krasil'nikov VG
    Farmakol Toksikol; 1977; 40(2):162-6. PubMed ID: 856625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of guanethidine and of reserpine on angiotensin responsiveness in man.
    Kállay K; Káldor A; Gachalyi B; Sebestyén
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):35-9. PubMed ID: 1150361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.